Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

In Silico Discovery and in vitro Evaluation of the Antifungal and Cytotoxicity Properties of Zeaxanthin and β-Carotene.

Created on 27 Aug 2026

Authors

Mohadese Panahi Moghadam, Soroush Sardari, Mohammad Norouzi Nejad, Mohammad Rahmati, Hamid Madanchi

Published in

Current microbiology. Volume 83. Issue 10. Aug 26, 2026. Epub Aug 26, 2026.

Abstract

The increasing drug resistance in pathogenic fungi has highlighted the need to identify novel molecular targets and safer antifungal compounds. In this study, a target-based chemoinformatics approach was employed to identify mannosyltransferase 2 (MNT2), key components of fungal cell wall glycosylation. Virtual screening of FDA-approved drugs against these fungal enzymes identified two natural carotenoids, Zeaxanthin and β-carotene, as promising candidates. The interaction of these compounds with MNTs was evaluated by molecular docking and ADMET analyses. The antifungal activity of Zeaxanthin and β-carotene was investigated in vitro against selected yeast and mold species, including Candida spp. and Aspergillus spp., and the MIC and MFC values were determined. Additionally, the cytotoxicity of these compounds on the L929 cell line and their hemolytic activity on human erythrocytes were assessed. The results showed that both compounds had mild but detectable antifungal activity, while exhibiting negligible cytotoxicity and hemolysis, even at high concentrations. FE-SEM analysis indicated that both compounds compromised the cell envelope and membrane integrity of C. albicans, leading to cell wall damage. Taken together, these findings suggest that Zeaxanthin and β-carotene, identified through a target-based chemoinformatics approach, could be considered as low-toxicity natural compounds with potential for topical or complementary applications in novel antifungal strategies.

PMID:
42645531
Bibliographic data and abstract were imported from PubMed on 27 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement